Accuray Aktie
WKN DE: A0MKWM / ISIN: US0043971052
21.06.2023 14:00:00
|
Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business
Partnership Will Support Accuray with SAP S/4HANA Implementation
TEANECK, N.J., June 21, 2023 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it is partnering with Accuray Incorporated (NASDAQ: ARAY) to support the company's deployment of SAP S/4HANA to obtain better data and analytics, and achieve greater business efficiencies. Accuray develops, manufactures, and sells radiotherapy systems for the precise, personalized treatment of cancer and certain neurologic conditions. As part of a global agreement, Cognizant is providing planning, design, implementation, change management, and program management for sales, procurement, manufacturing, distribution, installation, and service processes supported by SAP S/4HANA.
The medical technology industry faces pressure to streamline processes and reduce costs while continuing to innovate and introduce new products to market more quickly. Cognizant is working with Accuray to augment its infrastructure with the resources necessary for success.
"Cognizant is a trusted partner whose assistance will help us efficiently and effectively deploy SAP across our global organization. The new Enterprise Resource Planning (ERP) system will provide a platform to streamline and optimize business processes by making available real-time intelligence and insights to inform our decision making. Our team will have the resources needed to become nimbler in the way we operate, ultimately enabling us to enhance our support of the medical professionals involved in patient care," said GS JHA, Global Chief Information Officer and Chief Information Security Officer at Accuray.
"Cognizant is dedicated to partnering with healthcare technology companies focused on the development of lifesaving products," said Surya Gummadi, EVP and President, Cognizant Americas. "We're honored Accuray, a global leader in high-tech, targeted cancer treatment, has chosen Cognizant to help drive operational changes that will enable them to more efficiently develop, deliver and service radiotherapy solutions used worldwide to improve patient care."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
For more information, contact: | ||||
U.S. Name Ben Gorelick Email Benjamin.Gorelick@cognizant.com | Europe / APAC Name Christina Schneider Email Christina.Schneider@cognizant.com | India Name Rashmi Vasisht Email Rashmi.Vasisht@cognizant.com |
View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-is-partnering-with-accuray-to-accelerate-corporate-transformation-and-drive-operational-efficiency-in-their-radiation-therapy-business-301854500.html
SOURCE Cognizant Technology Solutions

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cognizant Corp.mehr Nachrichten
16:04 |
S&P 500-Papier Cognizant-Aktie: So viel Verlust hätte ein Cognizant-Investment von vor 3 Jahren eingefahren (finanzen.at) | |
25.03.25 |
NASDAQ 100 aktuell: NASDAQ 100 mittags auf grünem Terrain (finanzen.at) | |
25.03.25 |
Handel in New York: NASDAQ 100 beginnt Sitzung im Plus (finanzen.at) | |
25.03.25 |
Freundlicher Handel: S&P 500 bewegt sich zum Start im Plus (finanzen.at) | |
24.03.25 |
S&P 500-Titel Cognizant-Aktie: So viel Gewinn hätte ein Cognizant-Investment von vor einem Jahr eingefahren (finanzen.at) | |
20.03.25 |
Anleger in New York halten sich zurück: NASDAQ 100 gibt letztendlich nach (finanzen.at) | |
20.03.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 liegt am Donnerstagnachmittag im Minus (finanzen.at) | |
20.03.25 |
Schwache Performance in New York: NASDAQ 100 liegt am Donnerstagmittag im Minus (finanzen.at) |
Analysen zu Accuray IncShsmehr Analysen
Aktien in diesem Artikel
Accuray IncShs | 1,66 | -3,49% |
|
Cognizant Corp. | 68,97 | -1,34% |
|